HBS Alumni Angels of Greater New York (HBSAANY) has announced an investment in Galaxy Diagnostics, Inc., which is redefining the standard of care in stealth pathogen diagnosis. Our partner Dave Edwards led the deal for HBSAANY members, who invest individually as part of a single round on the same terms and timing. Announcement: https://www.linkedin.com/feed/update/urn:li:activity:7497775137988009984/
HBS Alumni Angels of Greater New York invest in Galaxy Diagnostics, deal led by Dave Edwards
Previous
Previous
Phase3D wins US Air Force contract to extend Fringe Inspection to ceramic composites
Next
Next

